Single-cell-RNA sequencing of bone marrow from mice exposed to chronic intermittent hypoxia
Iowa Research Online (The University of Iowa) · 22.07.2024
DOI: 10.25820/etd.007687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iowa Research Online (The University of Iowa), erschienen am 22.07.2024. Verfasst von Immaculate Edwin.
Abstract (Originalsprache)
Obstructive sleep apnea is characterized by recurrent episodes of upper airway closure with reduced or absent airflow during sleep. Epidemiological studies have indicated that moderate to severe levels of sleep apnea increase the risk of cancer incidence and mortality. Several studies suggest that chronic intermittent hypoxia, a feature of obstructive sleep apnea, is associated with increased aggressiveness of solid tumors, but only a few studies have studied its effects on hematological malignancies. An important factor in antitumor immune response is the expression of CD3+ and CD8+ T-cells. However, chronic intermittent hypoxia decreases the percent of CD3+ T-cells and obstructive sleep apnea decreases the percent of perforin positive CD8+ T-cells. Over the last decade, cancer immunotherapies have targeted inhibitory receptors such as LAG3 and PD1 to increase the percent of CD8+ cells in solid tumors. Meanwhile, CD3+ cells have been targeted in the bone marrow for treatment in hematological malignancies.
Schlagwörter
Zitieren
APA
Edwin, I. (2024). Single-cell-RNA sequencing of bone marrow from mice exposed to chronic intermittent hypoxia. Iowa Research Online (The University of Iowa). https://doi.org/10.25820/etd.007687
Vancouver
Edwin I. Single-cell-RNA sequencing of bone marrow from mice exposed to chronic intermittent hypoxia. Iowa Research Online (The University of Iowa). 2024. doi:10.25820/etd.007687
BibTeX
@article{Edwin2024,
author = {Edwin, Immaculate},
title = {Single-cell-RNA sequencing of bone marrow from mice exposed to chronic intermittent hypoxia},
journal = {Iowa Research Online (The University of Iowa)},
year = {2024},
doi = {10.25820/etd.007687}
}
EUVIMED